< 1 minute read
Sep. 18, 2021

compound 28

potent MAT2A inhibitor in vivo tool efficacy in MTAP-mut. xenograft (50 mpk SC) from fragment-based DD (frag. merging) J. Med. Chem., Apr. 26, 2021 AstraZeneca, Cambridge, UK

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in